These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 30928534

  • 1. Early clinical response and long-term radiographic progression in recent-onset rheumatoid arthritis: Clinical remission within six months remains the treatment target.
    Legrand J, Kirchgesner T, Sokolova T, Vande Berg B, Durez P.
    Joint Bone Spine; 2019 Oct; 86(5):594-599. PubMed ID: 30928534
    [Abstract] [Full Text] [Related]

  • 2. Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort.
    Lillegraven S, Prince FH, Shadick NA, Bykerk VP, Lu B, Frits ML, Iannaccone CK, Kvien TK, Haavardsholm EA, Weinblatt ME, Solomon DH.
    Ann Rheum Dis; 2012 May; 71(5):681-6. PubMed ID: 21994234
    [Abstract] [Full Text] [Related]

  • 3. Predictive value of a multi-biomarker disease activity score for clinical remission and radiographic progression in patients with early rheumatoid arthritis: a post-hoc study of the OPERA trial.
    Brahe CH, Østergaard M, Johansen JS, Defranoux N, Wang X, Bolce R, Sasso EH, Ørnbjerg LM, Hørslev-Petersen K, Stengaard-Pedersen K, Junker P, Ellingsen T, Ahlquist P, Lindegaard H, Linauskas A, Schlemmer A, Dam MY, Hansen I, Lottenburger T, Ammitzbøll C, Jørgensen A, Krintel SB, Raun J, Hetland ML.
    Scand J Rheumatol; 2019 Jan; 48(1):9-16. PubMed ID: 29985080
    [Abstract] [Full Text] [Related]

  • 4. Comparable long-term outcomes between DAS28-ESR remission criteria and ACR/EULAR definitions in patients with established rheumatoid arthritis.
    Ramírez J, Inciarte-Mundo J, Cuervo A, Celis R, Ruiz-Esquide V, Castellanos-Moreira R, Ponce A, Gómez-Puerta JA, Sanmartí R, Cañete JD.
    Clin Rheumatol; 2021 Jul; 40(7):2665-2672. PubMed ID: 33506371
    [Abstract] [Full Text] [Related]

  • 5. Remission vs low disease activity: function, quality of life and structural outcomes in the Early Rheumatoid Arthritis Study and Network.
    Nikiphorou E, Norton SJ, Carpenter L, Walsh DA, Creamer P, Dixey J, Young A, Kiely PDW, for ERAS and ERAN.
    Rheumatology (Oxford); 2020 Jun 01; 59(6):1272-1280. PubMed ID: 31580448
    [Abstract] [Full Text] [Related]

  • 6. Effect of Magnetic Resonance Imaging vs Conventional Treat-to-Target Strategies on Disease Activity Remission and Radiographic Progression in Rheumatoid Arthritis: The IMAGINE-RA Randomized Clinical Trial.
    Møller-Bisgaard S, Hørslev-Petersen K, Ejbjerg B, Hetland ML, Ørnbjerg LM, Glinatsi D, Møller J, Boesen M, Christensen R, Stengaard-Pedersen K, Madsen OR, Jensen B, Villadsen JA, Hauge EM, Bennett P, Hendricks O, Asmussen K, Kowalski M, Lindegaard H, Nielsen SM, Bliddal H, Krogh NS, Ellingsen T, Nielsen AH, Balding L, Jurik AG, Thomsen HS, Østergaard M.
    JAMA; 2019 Feb 05; 321(5):461-472. PubMed ID: 30721294
    [Abstract] [Full Text] [Related]

  • 7. Differences in disease activity measures in patients with rheumatoid arthritis who achieved DAS, SDAI, or CDAI remission but not Boolean remission.
    Aletaha D, Wang X, Zhong S, Florentinus S, Monastiriakos K, Smolen JS.
    Semin Arthritis Rheum; 2020 Apr 05; 50(2):276-284. PubMed ID: 31590930
    [Abstract] [Full Text] [Related]

  • 8. A multi-biomarker disease activity score can predict sustained remission in rheumatoid arthritis.
    Ma MHY, Defranoux N, Li W, Sasso EH, Ibrahim F, Scott DL, Cope AP.
    Arthritis Res Ther; 2020 Jun 24; 22(1):158. PubMed ID: 32580789
    [Abstract] [Full Text] [Related]

  • 9. Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis.
    Klarenbeek NB, Koevoets R, van der Heijde DM, Gerards AH, Ten Wolde S, Kerstens PJ, Huizinga TW, Dijkmans BA, Allaart CF.
    Ann Rheum Dis; 2011 Oct 24; 70(10):1815-21. PubMed ID: 21813548
    [Abstract] [Full Text] [Related]

  • 10. Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement.
    Wechalekar MD, Lester S, Proudman SM, Cleland LG, Whittle SL, Rischmueller M, Hill CL.
    Arthritis Rheum; 2012 May 24; 64(5):1316-22. PubMed ID: 22135142
    [Abstract] [Full Text] [Related]

  • 11. Implementation of a treat-to-target strategy in very early rheumatoid arthritis: results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort study.
    Vermeer M, Kuper HH, Hoekstra M, Haagsma CJ, Posthumus MD, Brus HL, van Riel PL, van de Laar MA.
    Arthritis Rheum; 2011 Oct 24; 63(10):2865-72. PubMed ID: 21647867
    [Abstract] [Full Text] [Related]

  • 12. Predictors of remission, erosive disease and radiographic progression in a Colombian cohort of early onset rheumatoid arthritis: a 3-year follow-up study.
    Quintana-Duque MA, Rondon-Herrera F, Mantilla RD, Calvo-Paramo E, Yunis JJ, Varela-Nariño A, Restrepo JF, Iglesias-Gamarra A.
    Clin Rheumatol; 2016 Jun 24; 35(6):1463-73. PubMed ID: 27041382
    [Abstract] [Full Text] [Related]

  • 13. Attainment and characteristics of clinical remission according to the new ACR-EULAR criteria in abatacept-treated patients with early rheumatoid arthritis: new analyses from the Abatacept study to Gauge Remission and joint damage progression in methotrexate (MTX)-naive patients with Early Erosive rheumatoid arthritis (AGREE).
    Smolen JS, Wollenhaupt J, Gomez-Reino JJ, Grassi W, Gaillez C, Poncet C, Le Bars M, Westhovens R.
    Arthritis Res Ther; 2015 Jun 11; 17(1):157. PubMed ID: 26063454
    [Abstract] [Full Text] [Related]

  • 14. Joint damage in rheumatoid arthritis progresses in remission according to the Disease Activity Score in 28 joints and is driven by residual swollen joints.
    Aletaha D, Smolen JS.
    Arthritis Rheum; 2011 Dec 11; 63(12):3702-11. PubMed ID: 21953215
    [Abstract] [Full Text] [Related]

  • 15. Grade and location of power Doppler are predictive of damage progression in rheumatoid arthritis patients in clinical remission by anti-tumour necrosis factor α.
    Raffeiner B, Grisan E, Botsios C, Stramare R, Rizzo G, Bernardi L, Punzi L, Ometto F, Doria A.
    Rheumatology (Oxford); 2017 Aug 01; 56(8):1320-1325. PubMed ID: 28431141
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical and ultrasound remission after 6 months of treat-to-target therapy in early rheumatoid arthritis: associations to future good radiographic and physical outcomes.
    Paulshus Sundlisæter N, Aga AB, Olsen IC, Hammer HB, Uhlig T, van der Heijde D, Kvien TK, Lillegraven S, Haavardsholm EA, ARCTIC study group.
    Ann Rheum Dis; 2018 Oct 01; 77(10):1421-1425. PubMed ID: 29934373
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.